INR 317.15
(-1.14%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 39.88 Million INR | 95.05% |
2022 | 20.44 Million INR | -61.34% |
2021 | 52.88 Million INR | 47.46% |
2020 | 35.86 Million INR | -35.46% |
2019 | 55.56 Million INR | 17.83% |
2018 | 47.15 Million INR | 68.64% |
2017 | 27.96 Million INR | 7.75% |
2016 | 25.95 Million INR | -0.98% |
2015 | 26.2 Million INR | 10.06% |
2014 | 23.81 Million INR | -8.38% |
2013 | 25.99 Million INR | 68.85% |
2012 | 15.39 Million INR | -33.02% |
2011 | 22.98 Million INR | -86.5% |
2010 | 170.25 Million INR | 36.75% |
2009 | 124.5 Million INR | -6.16% |
2008 | 132.67 Million INR | -15.19% |
2007 | 156.43 Million INR | 155.86% |
2006 | 61.14 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | 39.88 Million INR | 95.05% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 25.46 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 39.88 Million INR | 0.0% |
2022 Q4 | 20.44 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 36.95 Million INR | 0.0% |
2022 FY | 20.44 Million INR | -61.34% |
2022 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 52.88 Million INR | 47.46% |
2021 Q4 | 52.88 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 43.31 Million INR | 0.0% |
2020 Q4 | 35.86 Million INR | 0.0% |
2020 FY | 35.86 Million INR | -35.46% |
2020 Q2 | 22.12 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2019 FY | 55.56 Million INR | 17.83% |
2019 Q3 | - INR | -100.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 46.9 Million INR | 0.0% |
2019 Q4 | 55.56 Million INR | 0.0% |
2018 FY | 47.15 Million INR | 68.64% |
2018 Q4 | 47.15 Million INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2017 FY | 27.96 Million INR | 7.75% |
2016 FY | 25.95 Million INR | -0.98% |
2015 FY | 26.2 Million INR | 10.06% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | 23.81 Million INR | 0.0% |
2014 Q2 | 26.48 Million INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2014 FY | 23.81 Million INR | -8.38% |
2013 FY | 25.99 Million INR | 68.85% |
2013 Q2 | 13.37 Million INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q4 | 25.99 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2012 Q3 | - INR | -100.0% |
2012 Q2 | 43.75 Million INR | 0.0% |
2012 Q4 | 15.39 Million INR | 0.0% |
2012 FY | 15.39 Million INR | -33.02% |
2011 FY | 22.98 Million INR | -86.5% |
2010 FY | 170.25 Million INR | 36.75% |
2009 FY | 124.5 Million INR | -6.16% |
2008 FY | 132.67 Million INR | -15.19% |
2007 FY | 156.43 Million INR | 155.86% |
2006 FY | 61.14 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Sigachi Industries Limited | 707.2 Million INR | 94.361% |
Ind-Swift Limited | 640.91 Million INR | 93.778% |
Bajaj HealthCare Limited | 1.44 Billion INR | 97.231% |
Sakar Healthcare Limited | 277.32 Million INR | 85.62% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.959% |
Innova Captab Limited | 1.44 Billion INR | 97.231% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.875% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 98.25% |
Morepen Laboratories Limited | 2.48 Billion INR | 98.396% |
Mankind Pharma Limited | 15.53 Billion INR | 99.743% |
Sequent Scientific Limited | 3.46 Billion INR | 98.848% |
Wanbury Limited | 360.23 Million INR | 88.929% |
Laurus Labs Limited | 18.45 Billion INR | 99.784% |
Nectar Lifesciences Limited | 7.09 Billion INR | 99.438% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 99.402% |
Alembic Limited | 113.4 Million INR | 64.832% |
Hikal Limited | 3.03 Billion INR | 98.687% |
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.757% |
Neuland Laboratories Limited | 3.5 Billion INR | 98.862% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 99.206% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.841% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 99.061% |
Themis Medicare Limited | 705.74 Million INR | 94.349% |
RPG Life Sciences Limited | 1.01 Billion INR | 96.051% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.884% |
Lupin Limited | 49.53 Billion INR | 99.919% |
Amrutanjan Health Care Limited | 289.04 Million INR | 86.203% |
Wockhardt Limited | 6.4 Billion INR | 99.377% |
Vaishali Pharma Limited | 3.79 Million INR | -950.303% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 99.38% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 73.408% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.691% |
FDC Limited | 3.88 Billion INR | 98.975% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.937% |
Eris Lifesciences Limited | 1.89 Billion INR | 97.89% |
Venus Remedies Limited | 1.21 Billion INR | 96.723% |
ZIM Laboratories Limited | 812.62 Million INR | 95.092% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 96.633% |
Par Drugs and Chemicals Limited | 41.77 Million INR | 4.525% |
Caplin Point Laboratories Limited | 3.63 Billion INR | 98.901% |
Shilpa Medicare Limited | 3.44 Billion INR | 98.844% |
Albert David Limited | 436.12 Million INR | 90.856% |
Ajanta Pharma Limited | 8.28 Billion INR | 99.519% |
Hester Biosciences Limited | 755.81 Million INR | 94.724% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 98.275% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 98.891% |
Gufic Biosciences Limited | 2 Billion INR | 98.011% |
Windlas Biotech Limited | 621.89 Million INR | 93.587% |
Procter & Gamble Health Limited | 1.09 Billion INR | 96.345% |
Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | 88.499% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 96.775% |
Granules India Limited | 13 Billion INR | 99.693% |
Aarti Drugs Limited | 4.85 Billion INR | 99.179% |
Bal Pharma Limited | 878.11 Million INR | 95.458% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.85% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.96% |
Lincoln Pharmaceuticals Limited | 771.68 Million INR | 94.832% |
Medicamen Biotech Limited | 593.75 Million INR | 93.283% |
Unichem Laboratories Limited | 7.04 Billion INR | 99.434% |
Bafna Pharmaceuticals Limited | 296.41 Million INR | 86.546% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -56.411% |
Valiant Laboratories Limited | 100.15 Million INR | 60.181% |
Orchid Pharma Limited | 2.64 Billion INR | 98.491% |
Medico Remedies Limited | 163.37 Million INR | 75.589% |
Ind-Swift Laboratories Limited | 104.57 Million INR | 61.865% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.839% |
Brooks Laboratories Limited | 96.1 Million INR | 58.505% |
Syncom Formulations (India) Limited | 210.81 Million INR | 81.083% |
Piramal Enterprises Limited | - INR | -Infinity% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.825% |
NATCO Pharma Limited | 7 Billion INR | 99.431% |
Suven Life Sciences Limited | 7.08 Million INR | -462.879% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | 59.291% |
Strides Pharma Science Limited | 11.26 Billion INR | 99.646% |
Indoco Remedies Limited | 3.53 Billion INR | 98.87% |
Alpa Laboratories Limited | 136.65 Million INR | 70.817% |
Lasa Supergenerics Limited | 190.43 Million INR | 79.058% |
Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -169.605% |